Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Brain activation alterations with adjunctive deep transcranial magnetic stimulation in obsessive-compulsive disorder: an fMRI study

Key Takeaway: The study investigates the effectiveness of adjunctive deep transcranial magnetic stimulation (dTMS) in treating obsessive-compulsive disorder (OCD). Fifteen patients underwent ten sessions of dTMS, resulting in significant improvements in OCD, anxiety, and depressive symptoms. fMRI results showed decreased activation in the left caudate nucleus during cognitive tasks post-treatment, suggesting dTMS may effectively modulate brain activity associated with OCD.
Price reaction · baseline $2.49 (2023-11-21 close) · hit pre-market · 9 other BWAY headline(s) in the window, move may be shared
day 0 close
+10.6%
day 1
+17.1%
day 3 · peak
+23.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Significant improvement in OCD symptoms observed after dTMS treatment.
  • Reduction in activation of the left caudate nucleus indicates effective brain modulation.
  • Study supports dTMS as a promising adjunctive treatment for OCD.

Full Press Release Details

Background:

Obsessive-compulsive disorder (OCD) stands as one of the most prevalent neuropsychiatric disorders, surpassing the lifetime prevalence of schizophrenia and bipolar disorders. Many individuals with OCD do not adequately respond to currently available pharmacological and psychotherapeutic interventions. Consequently, there is growing interest in exploring adjunctive brain stimulation methods to address treatment resistance in OCD. This study aimed to investigate the effectiveness of adjunctive deep transcranial magnetic stimulation (dTMS) in alleviating OCD symptoms. Additionally, the impact of dTMS on brain region activation during the performance of the Stroop task was examined using functional magnetic resonance imaging (fMRI).

Methods:

Out of 41 assessed patients, 15 with OCD received ten sessions of high-frequency dTMS over a 2-week period, targeting the anterior cingulate cortex and the medial prefrontal cortex with the H7 coil. Clinical assessment utilized the Yale-Brown Obsessive-Compulsive Scale, the Hamilton Anxiety Rating Scale, and the Hamilton Depression Rating Scale before and after stimulation. fMRI was employed to measure brain region activation during the Stroop task.

Results:

Following the 2-week dTMS treatment, there was a significant improvement in obsessive-compulsive, anxiety, and depressive symptoms. Notably, a considerable decrease in the activation of the left caudate nucleus and adjacent white matter was observed during the Stroop task after dTMS treatment.

Conclusions:

This study presents initial evidence supporting the functional correlates of the effectiveness of dTMS as an adjunctive treatment approach for OCD.
Full Article:

Frequently Asked Questions

What is the focus of the dTMS study?

The study focuses on the effectiveness of adjunctive dTMS in alleviating OCD symptoms.

How many patients participated in the dTMS study?

Fifteen patients with OCD participated in the study.

What were the results of the dTMS treatment?

The treatment led to significant improvements in OCD, anxiety, and depressive symptoms.

What brain changes were observed after dTMS?

A decrease in activation of the left caudate nucleus was observed during cognitive tasks.

Last updated: Nov 22, 2023